Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Cardinal Health's revenue has swung between roughly negative 4% and positive 22% year over year across the last ten quarters, and its gross margin has stayed in a narrow 3.1% to 4.3% band, suggesting a distribution model with limited pricing power and growth that is largely volume and timing driven rather than…
Price trend, volume and key moving averages
Start with the evidence for owning the stock and the risks that can break the thesis.
Revenue and margin performance show volatile top-line growth and a gross margin confined to 3.1% to 4.3%, with operating margin improving to 1.1% in the latest quarter on $753M of operating income, though net margin remains thin at 0.8%.
Cardinal Health is actively combating opioid misuse in America, reinforcing its role in securing the pharmaceutical supply chain.
Q4 revenue of $64 billion marked an 8.4% beat, with the strongest sequential acceleration in 7 quarters, driven by 32% growth in Specialty Solutions.
CAH's trailing P/E of 24.57 and forward P/E of 16.92 suggest potential undervaluation relative to growth prospects.
Trailing total returns as of 11/18/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q4 2026Latest Nov 5, 2026 | $3.26+10.9% vs $2.94 | $67.5B+1.3% vs $66.7B |
Q3 2026 Aug 11, 2026 | $2.91+20.2% vs $2.42 | $63.7B-2.3% vs $65.2B |
Q2 2026 Apr 30, 2026 | $3.17+13.6% vs $2.79 | $60.9B-1.9% vs $62.1B |
Q1 2026 Feb 5, 2026 | $2.63+12.4% vs $2.34 | $65.6B+0.8% vs $65.1B |
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Banco Santander S.A. boosted its position in shares of Cardinal Health, Inc. (NYSE: CAH) by 11.8% in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 117,572 shares of the company's stock after buying an additional 12,420 shares during the quarter. Banco Santander
NVIDIA CEO Jensen Huang's resignation and market volatility bring into the spotlight five dividend growth stocks with earnings growth potential.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Benchmark CAH against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Cardinal Health, Inc. (CAH)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $279.25 | $65.4B | 35.79 | 14.23% | 0.71% | — | 0.74% | |
| $1091.67 | $127.4B | 27.11 | 12.36% | 1.12% | — | 0.28% | |
| $82.94 | $9.45B | 22.17 | 4.03% | 3.07% | 8.83% | — | |
| $0.09 | $6.74M | -0.01 | -74.19% | -6.72% | — | — | |
| $204.95 | $6.26B | 17.04 | -8.47% | 4.72% | 16.68% | 2.69% | |
| $278.70 | $670.89B | 42.40 | 6.05% | 16.2% | 19.55% | 1.83% |
Cardinal Health, Inc. (CAH) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Cardinal Health, Inc. (CAH) SEC filings — annual & quarterly reports (10-K, 10-Q)
Oct 1, 2026·SEC
Aug 11, 2026·SEC
Aug 11, 2026·SEC
Get notified when CAH posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Cardinal Health, Inc. (CAH) stock FAQ — growth, dividends, profitability & financials explained
Cardinal Health, Inc. (CAH) reported $257.75B in revenue over the trailing twelve months. Revenue was $254.25B in fiscal year 2026. That is 1282% more than the $18.39B of fiscal year 1997.
Cardinal Health, Inc. (CAH) grew revenue by 10.0% over the trailing twelve months, compared with the twelve months before.
Yes. Cardinal Health, Inc. (CAH) earned $1.82B in net income over the trailing twelve months (a 0.7% net margin).
Yes. Cardinal Health, Inc. (CAH) pays a dividend that yields 0.74% at the current price, a small yield.
Cardinal Health, Inc. (CAH) generated $4.90B in free cash flow over the trailing twelve months.